Disis ML - Search Results

1

Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockade.

Lu H, Wagner WM, Gad E, Yang Y, Duan H, Amon LM, Van Denend N, Larson ER, Chang A, Tufvesson H, Disis ML. Lu H, et al. Among authors: disis ml. J Immunol. 2010 May 1;184(9):5360-7. doi: 10.4049/jimmunol.0902997. Epub 2010 Mar 22. J Immunol. 2010. PMID: 20308630

2

Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein.

Disis ML, Gralow JR, Bernhard H, Hand SL, Rubin WD, Cheever MA. Disis ML, et al. J Immunol. 1996 May 1;156(9):3151-8. J Immunol. 1996. PMID: 8617935

3

Human HER-2/neu protein immunization circumvents tolerance to rat neu: a vaccine strategy for 'self' tumour antigens.

Disis ML, Shiota FM, Cheever MA. Disis ML, et al. Immunology. 1998 Feb;93(2):192-9. doi: 10.1046/j.1365-2567.1998.00424.x. Immunology. 1998. PMID: 9616368 Free PMC article.

4

Humoral epitope-spreading following immunization with a HER-2/neu peptide based vaccine in cancer patients.

Disis ML, Goodell V, Schiffman K, Knutson KL. Disis ML, et al. J Clin Immunol. 2004 Sep;24(5):571-8. doi: 10.1023/B:JOCI.0000040928.67495.52. J Clin Immunol. 2004. PMID: 15359116 Clinical Trial.

5

Adoptive T cell therapy of solid cancers.

Knutson KL, Wagner W, Disis ML. Knutson KL, et al. Among authors: disis ml. Cancer Immunol Immunother. 2006 Jan;55(1):96-103. doi: 10.1007/s00262-005-0706-1. Epub 2005 Oct 27. Cancer Immunol Immunother. 2006. PMID: 15891880 Free PMC article. Review.

6

IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice.

Knutson KL, Dang Y, Lu H, Lukas J, Almand B, Gad E, Azeke E, Disis ML. Knutson KL, et al. Among authors: disis ml. J Immunol. 2006 Jul 1;177(1):84-91. doi: 10.4049/jimmunol.177.1.84. J Immunol. 2006. PMID: 16785502

7

Immunoediting of cancers may lead to epithelial to mesenchymal transition.

Knutson KL, Lu H, Stone B, Reiman JM, Behrens MD, Prosperi CM, Gad EA, Smorlesi A, Disis ML. Knutson KL, et al. Among authors: disis ml. J Immunol. 2006 Aug 1;177(3):1526-33. doi: 10.4049/jimmunol.177.3.1526. J Immunol. 2006. PMID: 16849459

8

The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens.

Lu H, Knutson KL, Gad E, Disis ML. Lu H, et al. Among authors: disis ml. Cancer Res. 2006 Oct 1;66(19):9754-61. doi: 10.1158/0008-5472.CAN-06-1083. Cancer Res. 2006. PMID: 17018635

9

Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer.

Lu H, Goodell V, Disis ML. Lu H, et al. Among authors: disis ml. Expert Opin Ther Targets. 2007 Feb;11(2):235-44. doi: 10.1517/14728222.11.2.235. Expert Opin Ther Targets. 2007. PMID: 17227237 Review.

10

The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity.

Behrens MD, Wagner WM, Krco CJ, Erskine CL, Kalli KR, Krempski J, Gad EA, Disis ML, Knutson KL. Behrens MD, et al. Among authors: disis ml. Blood. 2008 Feb 1;111(3):1472-9. doi: 10.1182/blood-2007-10-117184. Epub 2007 Nov 20. Blood. 2008. PMID: 18029553 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters